A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects.
Molecules. 2019 Aug 16;24(16):2967. doi: 10.3390/molecules24162967.
Molecules. 2019.
PMID: 31426272
Free PMC article.
Clinical Trial.